Singlomics (Beijing DanXu) Biopharmaceuticals
PrivateLast Round
Strategic
Aug 2, 2022
Total Funding Raised
$61.9M
Company Overview
Singlomics (Beijing DanXu) Biopharmaceuticals is a biopharmaceutical company that discovers and develops antibody therapeutics for oncology, inflammation, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Singlomics (Beijing DanXu) Biopharmaceuticals Comps
Public and private peers based on sector, stage, and business model.
Singlomics (Beijing DanXu) Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 2, 2022 | ||||
| Series B | Feb 12, 2022 | ||||
| Series A | Sep 4, 2020 |
Singlomics (Beijing DanXu) Biopharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tencent Exploration | Strategic |
| Beijing Chang Development | Series A |
| Hillhouse Investment | Series B |
| Guoke Jiahe Capital | Series B |
| Hosen Capital | Series B |
| 健壹资本 | Series B, Strategic |
| Legend Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2022
Tencent Exploration and others participated in the strategic round.
- Feb 12, 2022
$47.3M round led by Hosen Capital and Legend Capital.
Singlomics (Beijing DanXu) Biopharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Singlomics (Beijing DanXu) Biopharmaceuticals's valuation, stock price, and market status.
